Molecular testing helps distinguish kidney cancer subtypes, ensuring patients get accurate diagnoses and treatment plans, ...
Then, in October 2024 at the age of 29, Davis received a diagnosis of estrogen receptor-positive, progesterone ...
I was diagnosed with colon cancer at 17, and while I’ll always be part of the AYA community, turning 40 has shown me the gift ...
Giredestrant plus Afinitor improved survival without progression in ER-positive advanced breast cancer. Phase 3 study results ...
Follow-up care and monitoring remain essential for patients with gastrointestinal stromal tumors (GIST) even after successful treatment, according to Dr. Weijing Sun, associate director at the ...
Munver: Kidney cancer treatment has evolved over the last few decades, and there has been a huge paradigm shift in how we treat it. For example, not all kidney cancers need to be treated. We are ...
Panelists discuss how thorough monitoring led to the discovery of asymptomatic throat cancer in a patient with HPV, ...
Glenn Hanna, MD, a head and neck cancer specialist at Dana-Farber Cancer Institute, provides a comprehensive overview of ...
Dr. Christina Cho, a hematologist/oncologist specializing in stem cell transplantation and cellular therapy at Hackensack Meridian Hackensack University Medical Center’s John Theurer Cancer Center, ...
Treatment for myelodysplastic syndromes has gradually advanced in anemia management and targeted therapies, according to Dr.
Kidney cancer care has seen advances over the past few decades, reflecting both improved diagnostic capabilities and less ...
The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results